Showing results (711-720 of 855) with videos related to
Sort By:
Pageof 86
Current Hematologic Malignancy Reports|April 25, 2018
Tyrosine Kinase Inhibitors in the Treatment of Chronic-Phase CML: Strategies for Frontline Decision-makingJames A Kennedy, Gabriela HobbsCurrent Hematologic Malignancy Reports|June 23, 2019
Considerations for the Treatment of Diffuse Large B Cell Lymphoma in the ElderlyYasir Khan, Elizabeth A BremCurrent Hematologic Malignancy Reports|October 12, 2018
Online and Social Media Resources for Patients with MDSNour Abuhadra, Aziz NazhaCurrent Hematologic Malignancy Reports|July 16, 2018
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia; Current Evidence, and Improving Outcomes Going ForwardJessica T Leonard, Brandon Hayes-LattinCurrent Hematologic Malignancy Reports|May 24, 2019
Key Role of Inflammation in Myeloproliferative Neoplasms: Instigator of Disease Initiation, Progression. and SymptomsLaura F Mendez Luque, Amanda L Blackmon, Gajalakshmi Ramanathan, et al.Current Hematologic Malignancy Reports|September 30, 2018
Leveraging Hypomethylating Agents for Better MDS TherapyTerrence J Bradley, Justin M Watts, Ronan T SwordsCurrent Hematologic Malignancy Reports|January 28, 2021
High-Risk Mantle Cell Lymphoma in the Era of Novel AgentsEdward Nabrinsky, Alexey V Danilov, Paul B KollerCurrent Hematologic Malignancy Reports|September 13, 2019
Venetoclax for the Treatment of Chronic Lymphocytic LeukemiaHerbert EradatCurrent Hematologic Malignancy Reports|July 31, 2019
The Role of PI3K Inhibition in Lymphoid MalignanciesGottfried von Keudell, Alison J MoskowitzCurrent Hematologic Malignancy Reports|May 10, 2011
The unique characteristics and management of patients over 60 years of age with classic Hodgkin lymphomaTeresa V Halbsguth, Boris Böll, Peter Borchmann, et al.Pageof 86